Abstract
The role of probiotics as adjunctive measures in the prevention of Clostridium difficile infection (CDI) has been controversial. However, a growing body of evidence has suggested that they have a role in primary prevention of CDI. Elements of this controversy are reviewed and the proposed mechanisms of action, the value and cost effectiveness of probiotics are addressed with a focus on three agents, Saccharomyces boulardii, Lactobacillus rhamnosus GG and the combination of Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, Lactobacillus rhamnosus CLR2 (Bio-K+).
Original language | English (US) |
---|---|
Pages (from-to) | 114-119 |
Number of pages | 6 |
Journal | Anaerobe |
Volume | 45 |
DOIs | |
State | Published - Jun 2017 |
Keywords
- Bio-K+
- C. difficile
- Lactobacillus acidophilus CL1285
- Lactobacillus casei LBC80R
- Lactobacillus rhamnosus CLR2
- Lactobacillus rhamnosus GG
- Probiotic
- Saccharomyces boulardii
ASJC Scopus subject areas
- Microbiology
- Infectious Diseases